Blumberg J - Search Results

1

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Ruszniewski P, Ducreux M, Chayvialle JA, Blumberg J, Cloarec D, Michel H, Raymond JM, Dupas JL, Gouerou H, Jian R, Genestin E, Bernades P, Rougier P. Ruszniewski P, et al. Among authors: blumberg j. Gut. 1996 Aug;39(2):279-83. doi: 10.1136/gut.39.2.279. Gut. 1996. PMID: 8977344 Free PMC article.

2

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.

O'Toole D, Ducreux M, Bommelaer G, Wemeau JL, Bouché O, Catus F, Blumberg J, Ruszniewski P. O'Toole D, et al. Among authors: blumberg j. Cancer. 2000 Feb 15;88(4):770-6. doi: 10.1002/(sici)1097-0142(20000215)88:4<770::aid-cncr6>3.0.co;2-0. Cancer. 2000. PMID: 10679645 Clinical Trial.

3

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors.

Ducreux M, Ruszniewski P, Chayvialle JA, Blumberg J, Cloarec D, Michel H, Raymond JM, Dupas JL, Gouerou H, Jian R, Genestin E, Hammel P, Rougier P. Ducreux M, et al. Among authors: blumberg j. Am J Gastroenterol. 2000 Nov;95(11):3276-81. doi: 10.1111/j.1572-0241.2000.03210.x. Am J Gastroenterol. 2000. PMID: 11095353 Clinical Trial.

4

Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis. A phase II prospective multicentre study.

Lévy P, Hastier P, Arotçarena R, Bartolie E, Bougeard-Julien M, Blumberg J, O'Toole D, Ruszniewski P. Lévy P, et al. Among authors: blumberg j. Pancreatology. 2004;4(3-4):229-32. doi: 10.1159/000078434. Epub 2004 May 12. Pancreatology. 2004. PMID: 15148442 Clinical Trial.

5

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P; CLARINET Investigators. Caplin ME, et al. Among authors: blumberg j. N Engl J Med. 2014 Jul 17;371(3):224-33. doi: 10.1056/NEJMoa1316158. N Engl J Med. 2014. PMID: 25014687 Free article. Clinical Trial.

6

Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.

Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P. Kuhn JM, et al. Among authors: blumberg j. J Clin Endocrinol Metab. 2000 Apr;85(4):1487-91. doi: 10.1210/jcem.85.4.6548. J Clin Endocrinol Metab. 2000. PMID: 10770186 Clinical Trial.

7

Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans.

Lamrani A, Vidon N, Sogni P, Nepveux P, Catus F, Blumberg J, Chaussade S. Lamrani A, et al. Among authors: blumberg j. Br J Clin Pharmacol. 1997 Jan;43(1):65-70. doi: 10.1111/j.1365-2125.1997.tb00034.x. Br J Clin Pharmacol. 1997. PMID: 9056054 Free article. Clinical Trial.

8

Efficacy and tolerability of the long-acting somatostatin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acromegalic patients. French Multicenter Study Group on Lanreotide in Acromegaly.

Chanson P, Leselbaum A, Blumberg J, Schaison G. Chanson P, et al. Among authors: blumberg j. Pituitary. 2000 May;2(4):269-76. doi: 10.1023/a:1009961116472. Pituitary. 2000. PMID: 11081148 Clinical Trial.

9

Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae.

Gayral F, Campion JP, Regimbeau JM, Blumberg J, Maisonobe P, Topart P, Wind P; Lanreotide Digestive Fistula. Gayral F, et al. Among authors: blumberg j. Ann Surg. 2009 Dec;250(6):872-7. doi: 10.1097/sla.0b013e3181b2489f. Ann Surg. 2009. PMID: 19953707 Clinical Trial.

10

Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

Mariani P, Blumberg J, Landau A, Lebrun-Jezekova D, Botton E, Beatrix O, Mayeur D, Herve R, Maisonobe P, Chauvenet L. Mariani P, et al. Among authors: blumberg j. J Clin Oncol. 2012 Dec 10;30(35):4337-43. doi: 10.1200/JCO.2011.40.5712. Epub 2012 Oct 29. J Clin Oncol. 2012. PMID: 23109694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters